ATE334671T1 - Wortmanninanaloge und verfahren zu deren verwendung - Google Patents
Wortmanninanaloge und verfahren zu deren verwendungInfo
- Publication number
- ATE334671T1 ATE334671T1 AT02766286T AT02766286T ATE334671T1 AT E334671 T1 ATE334671 T1 AT E334671T1 AT 02766286 T AT02766286 T AT 02766286T AT 02766286 T AT02766286 T AT 02766286T AT E334671 T1 ATE334671 T1 AT E334671T1
- Authority
- AT
- Austria
- Prior art keywords
- analogs
- wordman
- inhibiting
- mammals
- subject
- Prior art date
Links
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 102000003993 Phosphatidylinositol 3-kinases Human genes 0.000 abstract 1
- 108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000005740 tumor formation Effects 0.000 abstract 1
- QDLHCMPXEPAAMD-QAIWCSMKSA-N wortmannin Chemical class C1([C@]2(C)C3=C(C4=O)OC=C3C(=O)O[C@@H]2COC)=C4[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O QDLHCMPXEPAAMD-QAIWCSMKSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
- Compounds Of Unknown Constitution (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32213901P | 2001-09-14 | 2001-09-14 | |
| US32214301P | 2001-09-14 | 2001-09-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE334671T1 true ATE334671T1 (de) | 2006-08-15 |
Family
ID=26983283
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02766286T ATE334671T1 (de) | 2001-09-14 | 2002-09-16 | Wortmanninanaloge und verfahren zu deren verwendung |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1435941B8 (enExample) |
| JP (1) | JP4540986B2 (enExample) |
| AT (1) | ATE334671T1 (enExample) |
| AU (1) | AU2002330029B2 (enExample) |
| CA (1) | CA2458318C (enExample) |
| DE (1) | DE60213633T2 (enExample) |
| MX (1) | MXPA04002445A (enExample) |
| WO (1) | WO2003024183A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7081475B2 (en) | 2001-09-14 | 2006-07-25 | Prolx Pharmaceuticals Corp. | Wortmannin analogs and methods of using same |
| DE10219545A1 (de) * | 2002-04-26 | 2003-11-06 | Lang Florian | Regulation der Apoptose |
| US7230139B2 (en) | 2002-12-05 | 2007-06-12 | Gemin X Biotechnologies | Diterpenoid compounds, compositions thereof and their use as anti-cancer or anti-fungal agents |
| MXPA05011248A (es) * | 2003-04-23 | 2005-12-14 | Wyeth Corp | Derivados de wortmanina solubles en agua. |
| DE102004043463A1 (de) * | 2004-06-09 | 2006-02-09 | Heinz Voigt | Mittel zur Krebsbekämpfung unter Verwendung von Schimmelpilzextrakten |
| EP1901738A4 (en) * | 2004-07-09 | 2009-11-11 | Prolx Pharmaceuticals Inc | WORDMANNIN ANALOGA AND METHOD FOR USE IN COMBINATION WITH CHEMOTHERAPEAN AGENTS |
| PE20060608A1 (es) * | 2004-10-13 | 2006-08-22 | Wyeth Corp | Analogos de 17-hidroxiwortmanina como inhibidores de pi3k |
| WO2006132675A2 (en) * | 2004-12-20 | 2006-12-14 | University Of South Florida | Xiap-targeted prostate cancer therapy |
| WO2007086943A2 (en) * | 2005-09-01 | 2007-08-02 | Beth Israel Deaconess Medical Center | Wortmannin conjugates and uses thereof |
| US20070116736A1 (en) * | 2005-11-23 | 2007-05-24 | Argentieri Dennis C | Local vascular delivery of PI3 kinase inhibitors alone or in combination with sirolimus to prevent restinosis following vascular injury |
| PL1965790T3 (pl) * | 2005-12-30 | 2012-05-31 | Arizona Board Of Regents Acting On Behalf Of The Univ Of Arizona | Metabolity analogów wortmaniny i sposoby ich stosowania |
| EP2012794B1 (en) * | 2006-04-13 | 2014-09-17 | The Trustees of Columbia University in the City of New York | Compositions and intraluminal devices for inhibiting vascular stenosis |
| JP2013527247A (ja) * | 2010-06-04 | 2013-06-27 | オンコシレオン インク． | ウォルトマンニンアナログによる併用の癌治療 |
| JP2013527248A (ja) * | 2010-06-04 | 2013-06-27 | オンコシレオン インク． | ウォルトマンニンアナログによる癌の処置 |
| US11197854B1 (en) | 2018-11-14 | 2021-12-14 | National Technology & Engineering Solutions Of Sandia, Llc | Inhibitors for targeting flaviviruses |
| CA3124330A1 (en) | 2018-12-21 | 2020-06-25 | Daiichi Sankyo Company, Limited | Combination of antibody-drug conjugate and kinase inhibitor |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2302021A (en) * | 1996-10-16 | 1997-01-08 | Lilly Co Eli | Inhibiting bone loss or resorption |
-
2002
- 2002-09-16 EP EP02766286A patent/EP1435941B8/en not_active Expired - Lifetime
- 2002-09-16 DE DE60213633T patent/DE60213633T2/de not_active Expired - Lifetime
- 2002-09-16 AU AU2002330029A patent/AU2002330029B2/en not_active Ceased
- 2002-09-16 JP JP2003528088A patent/JP4540986B2/ja not_active Expired - Fee Related
- 2002-09-16 WO PCT/US2002/029365 patent/WO2003024183A2/en not_active Ceased
- 2002-09-16 CA CA2458318A patent/CA2458318C/en not_active Expired - Fee Related
- 2002-09-16 AT AT02766286T patent/ATE334671T1/de not_active IP Right Cessation
- 2002-09-16 MX MXPA04002445A patent/MXPA04002445A/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003024183A3 (en) | 2003-06-12 |
| EP1435941A2 (en) | 2004-07-14 |
| EP1435941A4 (en) | 2004-12-08 |
| AU2002330029B2 (en) | 2006-07-06 |
| EP1435941B1 (en) | 2006-08-02 |
| CA2458318A1 (en) | 2003-03-27 |
| WO2003024183A2 (en) | 2003-03-27 |
| DE60213633D1 (de) | 2006-09-14 |
| JP4540986B2 (ja) | 2010-09-08 |
| CA2458318C (en) | 2011-03-15 |
| JP2005507880A (ja) | 2005-03-24 |
| MXPA04002445A (es) | 2005-07-25 |
| DE60213633T2 (de) | 2007-11-08 |
| EP1435941B8 (en) | 2006-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE334671T1 (de) | Wortmanninanaloge und verfahren zu deren verwendung | |
| DE69815090D1 (de) | Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen | |
| ES2189235T3 (es) | 6-fenilfenantridinas sustituidas. | |
| DE60118921D1 (de) | Verfahren und Zusammensetzungen unter Verwendung von Chinazolinonen | |
| GB0209891D0 (en) | Novel compounds | |
| DE60013555D1 (de) | Verwendung von 4-h-1-benzopyran-4-on-derivaten als inhibitoren der proliferation von glatten muskelzellen | |
| DE59905858D1 (de) | Verwendung von pit-emulsionen | |
| DE60334570D1 (de) | Verfahren zu herstellung von metallnanoteilchen | |
| TR200201638T2 (tr) | Yeni imidazo[1,3,5]triazinonlar ve kullanımları | |
| DE50212455D1 (de) | Verwendung von Dimerdiolen | |
| EP1565262A4 (en) | PROCESS FOR PREPARING A COMPOSITION COMPRISING A SUPPLEMENTED ACTIVATED CATALYST | |
| DE60221972D1 (de) | Verfahren zur gewichtsverminderung von gipsbauplatten | |
| ATE202483T1 (de) | Immuntolerante prothrombinkomplex-präparation | |
| DE50114181D1 (de) | Verwendung von 1-phenyl-3-dimethylamino-propan-verbindungen zur therapie der harninkontinenz | |
| DE60226522D1 (de) | Wortmannin-Analoge und Verfahren zu deren Verwendung | |
| ATE314066T1 (de) | Verwendung von buprenorphin zur therapie der harninkontinenz | |
| DE69918996D1 (de) | Verfahren zur herstellung von allyl-/ethylenischen copolymerisaten | |
| DE60011801D1 (de) | Benzoxa- und benzthiazolylsulfamate sowie ihre verwendung als steroid-sulfataseinhibitoren | |
| ATE314070T1 (de) | Verwendung von pyridoindolonderivaten zur herstellung von antikrebsmitteln | |
| IL148726A0 (en) | Method of calculating correct religious hijri calendar | |
| ATA16522002A (de) | Verfahren zur bestimmung der aktivität von diaminooxidase | |
| DE60127917D1 (de) | Verwendung von gamma-CEHC als Antioxidantien | |
| EP1965790A4 (en) | METABOLITES OF WORTMANNINE ANALOGS AND METHODS OF USE | |
| DE60116664D1 (de) | Indolocarbazol-antikrebsmittel und verfahren zu ihrer verwendung | |
| ATE345395T1 (de) | Verfahren zur bestimmung der syntheseaktivität von hydrolasen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |